MIRA
MIRA Pharmaceuticals, Inc. Common StockNASDAQHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$42.86M
P/E Ratio
—
EPS
$-1.35
Beta
1.94
52W High
$2.45
52W Low
$0.90
50-Day MA
$1.12
200-Day MA
$1.37
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About MIRA Pharmaceuticals, Inc. Common Stock
MIRA Pharmaceuticals, Inc. is a clinical development stage biopharmaceutical company. The company is headquartered in Baltimore, Maryland.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -165.90% |
| Return on Assets | -93.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.25 |
| Price-to-Book | 4.13 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -1.45 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $42.02M |
| Float | $35.03M |
| % Insiders | 16.71% |
| % Institutions | 5.20% |
Historical Volatility
HV 10-Day
55.39%
HV 20-Day
50.08%
HV 30-Day
96.75%
HV 60-Day
76.86%
HV Rank
74.6%
Volatility is currently contracting
Data last updated: 4/30/2026